| 国盛投资 |
陆肖天 |
增持 |
15520000 |
4822.20万股 |
0.05% |
好仓 |
2020-11-27 |
| 国盛投资 |
张航嘉 |
增持 |
15520000 |
4822.20万股 |
0.05% |
好仓 |
2020-11-27 |
| 国盛投资 |
严凯聃 |
增持 |
15520000 |
4822.20万股 |
0.05% |
好仓 |
2020-11-27 |
| 国盛投资 |
周皓 |
增持 |
15520000 |
4822.20万股 |
0.05% |
好仓 |
2020-11-27 |
| 富汇国际集团控股 |
Victory Way Global Company Limited |
增持 |
1200000000 |
120000.00万股 |
0.75% |
好仓 |
2020-11-27 |
| 富汇国际集团控股 |
刘心艺 |
增持 |
1200000000 |
120000.00万股 |
0.75% |
好仓 |
2020-11-27 |
| 禹洲集团 |
郭英兰 |
增持 |
122238770 |
336507.26万股 |
0.59% |
好仓 |
2020-11-27 |
| 禹洲集团 |
林龙安 |
增持 |
122238770 |
336507.26万股 |
0.59% |
好仓 |
2020-11-27 |
| 禹洲集团 |
Studious Profits Limited |
增持 |
61126481 |
166977.17万股 |
0.29% |
好仓 |
2020-11-27 |
| 中华银科技 |
江建军 |
增持 |
42446000 |
20804.95万股 |
0.08% |
好仓 |
2020-11-27 |
| 亚盛医药-B |
Morgan Stanley |
增持 |
6861667 |
1139.43万股 |
0.05% |
好仓 |
2020-11-27 |
| 金科服务 |
Morgan Stanley |
增持 |
2392701 |
1420.46万股 |
0.11% |
好仓 |
2020-11-27 |
| 启明医疗-B |
Jiaxing Demenghong Investment Partnership (Limited Partnership) |
增持 |
13628724 |
1362.87万股 |
0.03% |
好仓 |
2020-11-27 |
| 启明医疗-B |
Jiaxing Dechanghong Investment Partnership (Limited Partnership) |
增持 |
13628724 |
1362.87万股 |
0.03% |
好仓 |
2020-11-27 |
| 启明医疗-B |
Jiaxing Dechanghong Investment Partnership (Limited Partnership) |
减持 |
-13628724 |
0.00万股 |
0.00% |
好仓 |
2020-11-27 |
| 启明医疗-B |
Jiaxing Demenghong Investment Partnership (Limited Partnership) |
减持 |
-13628724 |
0.00万股 |
0.00% |
好仓 |
2020-11-27 |
| 启明医疗-B |
Sequoia Capital China Venture Fund IV, L.P. |
减持 |
-18522200 |
0.00万股 |
0.00% |
好仓 |
2020-11-27 |
| 启明医疗-B |
SC China Holding Limited |
减持 |
-18522200 |
0.00万股 |
0.00% |
好仓 |
2020-11-27 |
| 启明医疗-B |
沈南鹏 |
减持 |
-18522200 |
0.00万股 |
0.00% |
好仓 |
2020-11-27 |
| ESR |
Morgan Stanley |
减持 |
-127036501 |
4367.25万股 |
0.01% |
好仓 |
2020-11-27 |
